EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 47 filers reported holding EDGEWISE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,536,875 | -26.1% | 3,933,137 | 0.0% | 0.50% | -23.7% |
| Q2 2023 | $30,481,812 | +16.2% | 3,933,137 | 0.0% | 0.65% | +11.3% |
| Q1 2023 | $26,234,024 | -25.4% | 3,933,137 | 0.0% | 0.58% | -19.6% |
| Q4 2022 | $35,162,245 | -9.1% | 3,933,137 | 0.0% | 0.73% | -5.5% |
| Q3 2022 | $38,702,000 | +23.6% | 3,933,137 | 0.0% | 0.77% | +19.2% |
| Q2 2022 | $31,308,000 | -17.9% | 3,933,137 | 0.0% | 0.65% | -24.3% |
| Q1 2022 | $38,151,000 | -36.5% | 3,933,137 | 0.0% | 0.85% | -32.4% |
| Q4 2021 | $60,098,000 | -8.0% | 3,933,137 | 0.0% | 1.26% | -1.0% |
| Q3 2021 | $65,290,000 | -22.2% | 3,933,137 | 0.0% | 1.27% | -14.5% |
| Q2 2021 | $83,894,000 | -34.4% | 3,933,137 | 0.0% | 1.49% | -44.5% |
| Q1 2021 | $127,827,000 | – | 3,933,137 | – | 2.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $15,071,000 | 7.43% |
| Cormorant Asset Management, LP | 4,682,874 | $45,424,000 | 3.49% |
| Novo Holdings A/S | 5,587,207 | $54,196,000 | 2.86% |
| Orbimed Advisors | 13,944,680 | $135,263,000 | 2.19% |
| Opaleye Management Inc. | 303,000 | $2,939,000 | 0.91% |
| DAFNA Capital Management LLC | 356,750 | $3,460,000 | 0.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $38,151,000 | 0.85% |
| EcoR1 Capital, LLC | 2,359,808 | $22,890,000 | 0.72% |
| RA Capital Management | 2,613,623 | $25,352,000 | 0.55% |
| HighVista Strategies LLC | 59,733 | $579,000 | 0.37% |